All for Joomla All for Webmasters

Autoantibodies to domain 1 of beta 2 glycoprotein I determined using a novel chemiluminescence immunoassay demonstrate association with thrombosis in patients with antiphospholipid syndrome

Rate this item
(0 votes)

Utility:

Anti-B2GPI-D1 IgG are present more frequently and in higher titers in APS patients with thrombotic complications than in those without. QUANTA Flash B2GP1 Domain 1 chemiluminescence assay appears to be superior to full-length B2GPI assays for the risk assessment of thrombotic events in APS patients

Additional Info

Read 176 times

Werfen.com. All rights Reserved. Privacy Policy | Cookies Policy | Terms of Service

No Internet Connection